These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36047134)

  • 1. Cerebrospinal Fluid Interleukin-6 in Immune Checkpoint Inhibitor-Induced Autoimmune Meningoencephalitis.
    Mizukami T; Masuda T; Kimura N; Uchida H; Jikumaru M; Hanaoka T; Matsubara E
    Tohoku J Exp Med; 2022 Sep; 258(2):159-165. PubMed ID: 36047134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of meningoencephalitis and polyradiculoneuropathy induced by combination therapy with ipilimumab and nivolumab].
    Ohno N; Sugimoto T; Giga M; Naito H; Kono T; Nomura E
    Rinsho Shinkeigaku; 2021 Oct; 61(10):658-662. PubMed ID: 34565749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
    Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J
    JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.
    Kapadia RK; Ney DE; Hannan M; Farley M; Pastula DM; Piquet AL
    J Neuroimmunol; 2020 Jul; 344():577259. PubMed ID: 32416558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
    Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
    J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report.
    Yaura K; Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
    Tohoku J Exp Med; 2021 Aug; 254(4):253-256. PubMed ID: 34373422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction.
    Hartmann A; Paparoupa M; Volkmer BG; Rompel R; Wittig A; Schuppert F
    J Oncol Pharm Pract; 2020 Oct; 26(7):1774-1779. PubMed ID: 32164491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningoencephalitis in relapsing polychondritis: A case report.
    Matsumoto H; Tokimura R; Fujita Y; Matsuoka N; Asano T; Sato S; Temmoku J; Yashiro-Furuya M; Yoshida K; Takahashi R; Tanaka S; Itagaki Y; Honma M; Matsuda N; Watanabe H; Migita K; Kanai K
    Medicine (Baltimore); 2021 Jun; 100(24):e26315. PubMed ID: 34128872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab.
    Ueda K; Suekane S; Kurose H; Ito N; Ogasawara N; Hiroshige T; Chikui K; Ejima K; Uemura K; Nakiri M; Nishihara K; Igawa T
    Jpn J Clin Oncol; 2022 May; 52(5):479-485. PubMed ID: 35141749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis.
    Nada A; Bhat R; Cousins J
    Curr Probl Cancer; 2021 Feb; 45(1):100644. PubMed ID: 32888700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autopsy Case of Meningoencephalitis Induced by Nivolumab and Ipilimumab in a Patient Being Treated for Non-small Cell Lung Cancer.
    Shiraha K; Watanabe H; Fujiwara K; Goda M; Inoue T; Fujiwara M; Matsuoka S; Takigawa Y; Mitsumune S; Kudo K; Sato A; Sato K; Shinno Y; Shibayama T
    Intern Med; 2024 Dec; 63(24):3345-3351. PubMed ID: 38631854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of meningoencephalitis associated with pembrolizumab treated for squamous cell lung cancer].
    Yonenobu Y; Ishijima M; Toyooka K; Fujimura H
    Rinsho Shinkeigaku; 2019 Feb; 59(2):105-108. PubMed ID: 30700688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography: A case report.
    Abe K; Ishikawa Y; Fujiwara M; Yukawa H; Yanagihara T; Takei S; Arioka H; Kita Y
    Medicine (Baltimore); 2022 Jan; 101(2):e28428. PubMed ID: 35029182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.
    Bir Yucel K; Sutcuoglu O; Yazıcı O; Yıldız Y; Şenol E; Uner A
    J Oncol Pharm Pract; 2023 Apr; 29(3):760-763. PubMed ID: 35938177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Checkpoint Inhibitor Induced Acute Liver Failure.
    Ezeani C; Ugochukwu O; Johnson A; Lavie D; Chauvin R
    J Investig Med High Impact Case Rep; 2024; 12():23247096241261505. PubMed ID: 38895944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors.
    Gul A; Stewart TF; Mantia CM; Shah NJ; Gatof ES; Long Y; Allman KD; Ornstein MC; Hammers HJ; McDermott DF; Atkins MB; Hurwitz M; Rini BI
    J Clin Oncol; 2020 Sep; 38(27):3088-3094. PubMed ID: 32491962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.
    Kopecký J; Kubeček O; Geryk T; Slováčková B; Hoffmann P; Žiaran M; Priester P
    J Med Case Rep; 2018 Sep; 12(1):262. PubMed ID: 30217214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
    Ikeda T; Ishihara H; Nemoto Y; Tachibana H; Fukuda H; Yoshida K; Takagi T; Iizuka J; Hashimoto Y; Ishida H; Kondo T; Tanabe K
    Urol Oncol; 2021 Oct; 39(10):735.e9-735.e16. PubMed ID: 34172370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT].
    Ishii M; Takezawa K; Imamura R; Fukuhara S; Fujita K; Uemura M; Kiuchi H; Nonomura N
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):109-112. PubMed ID: 35444079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system complications associated with immune checkpoint inhibitors.
    Vogrig A; Muñiz-Castrillo S; Joubert B; Picard G; Rogemond V; Marchal C; Chiappa AM; Chanson E; Skowron F; Leblanc A; Ducray F; Honnorat J
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):772-778. PubMed ID: 32312871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.